Since MDA-MB-231 is a triple negative breast cell line that can only represent a specific subset of breast cancer, we tried to confirm whether ETS1 inhibits the proliferation of tumor cells with MCF-7 cells (ER+, PR+ and HER2− cell; Supplementary Figure 4). This evidence concerns the gene ERBB2 and breast carcinoma.